REPORT ID 6302

Asia-Pacific Neurological Biomarkers Market Report 2019

Publish Date
2019
Pages
112
Format
Electronic (PDF)

In this report, the Asia-Pacific Neurological Biomarkers market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Neurological Biomarkers for these regions, from   2019 to 2025 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Neurological Biomarkers market competition by top manufacturers/players, with Neurological Biomarkers sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Thermo Fisher Scientific (U.S.)
    Qiagen (Germany)
    Myriad RBM (U.S.)
    Proteome Sciences (UK)
    Banyan Biomarkers (U.S.)
    Cisbio Bioassays (U.S.)
    Abiant (U.S.)
    Acumen Pharmaceuticals (U.S.)
    Proteosys (Germany)
    Alseres Pharmaceuticals (U.S.)
    Athena Diagnostics (U.S.)

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Alzheimer's Disease
    Parkinson's Disease
    Autism Spectrum Disorder
    Multiple Sclerosis
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Genomics
    Proteomics
    Metabolomics
    Imaging
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Neurological Biomarkers Market  Report 2019
1 Neurological Biomarkers Overview
    1.1 Product Overview and Scope of Neurological Biomarkers
    1.2 Classification of Neurological Biomarkers by Product Category
        1.2.1 Asia-Pacific Neurological Biomarkers Market Size (Sales) Comparison by Types ( 2014-2024)
        1.2.2 Asia-Pacific Neurological Biomarkers Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Alzheimer's Disease
        1.2.4 Parkinson's Disease
        1.2.5 Autism Spectrum Disorder
        1.2.6 Multiple Sclerosis
        1.2.7 Other
    1.3 Asia-Pacific Neurological Biomarkers Market by Application/End Users
        1.3.1 Asia-Pacific Neurological Biomarkers Sales (Volume) and Market Share Comparison by Applications ( 2014-2024)
        1.3.2 Genomics
        1.3.3 Proteomics
        1.3.4 Metabolomics
        1.3.5 Imaging
        1.3.6 Other
    1.4 Asia-Pacific Neurological Biomarkers Market by Region
        1.4.1 Asia-Pacific Neurological Biomarkers Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 China Status and Prospect ( 2014-2024)
        1.4.3 Japan Status and Prospect ( 2014-2024)
        1.4.4 South Korea Status and Prospect ( 2014-2024)
        1.4.5 Taiwan Status and Prospect ( 2014-2024)
        1.4.6 India Status and Prospect ( 2014-2024)
        1.4.7 Southeast Asia Status and Prospect ( 2014-2024)
        1.4.8 Australia Status and Prospect ( 2014-2024)
    1.5 Asia-Pacific Market Size (Value and Volume) of Neurological Biomarkers ( 2014-2024)
        1.5.1 Asia-Pacific Neurological Biomarkers Sales and Growth Rate ( 2014-2024)
        1.5.2 Asia-Pacific Neurological Biomarkers Revenue and Growth Rate ( 2014-2024)

2 Asia-Pacific Neurological Biomarkers Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Neurological Biomarkers Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Neurological Biomarkers Sales Volume and Market Share of Key Players/Suppliers ( 2014-2019)
        2.1.2 Asia-Pacific Neurological Biomarkers Revenue and Share by Players/Suppliers ( 2014-2019)
    2.2 Asia-Pacific Neurological Biomarkers (Volume and Value) by Type
        2.2.1 Asia-Pacific Neurological Biomarkers Sales and Market Share by Type ( 2014-2019)
        2.2.2 Asia-Pacific Neurological Biomarkers Revenue and Market Share by Type ( 2014-2019)
    2.3 Asia-Pacific Neurological Biomarkers (Volume) by Application
    2.4 Asia-Pacific Neurological Biomarkers (Volume and Value) by Region
        2.4.1 Asia-Pacific Neurological Biomarkers Sales and Market Share by Region ( 2014-2019)
        2.4.2 Asia-Pacific Neurological Biomarkers Revenue and Market Share by Region ( 2014-2019)

3 China Neurological Biomarkers (Volume, Value and Sales Price)
    3.1 China Neurological Biomarkers Sales and Value ( 2014-2019)
        3.1.1 China Neurological Biomarkers Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 China Neurological Biomarkers Revenue and Growth Rate ( 2014-2019)
        3.1.3 China Neurological Biomarkers Sales Price Trend ( 2014-2019)
    3.2 China Neurological Biomarkers Sales Volume and Market Share by Type
    3.3 China Neurological Biomarkers Sales Volume and Market Share by Application

4 Japan Neurological Biomarkers (Volume, Value and Sales Price)
    4.1 Japan Neurological Biomarkers Sales and Value ( 2014-2019)
        4.1.1 Japan Neurological Biomarkers Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Japan Neurological Biomarkers Revenue and Growth Rate ( 2014-2019)
        4.1.3 Japan Neurological Biomarkers Sales Price Trend ( 2014-2019)
    4.2 Japan Neurological Biomarkers Sales Volume and Market Share by Type
    4.3 Japan Neurological Biomarkers Sales Volume and Market Share by Application

5 South Korea Neurological Biomarkers (Volume, Value and Sales Price)
    5.1 South Korea Neurological Biomarkers Sales and Value ( 2014-2019)
        5.1.1 South Korea Neurological Biomarkers Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 South Korea Neurological Biomarkers Revenue and Growth Rate ( 2014-2019)
        5.1.3 South Korea Neurological Biomarkers Sales Price Trend ( 2014-2019)
    5.2 South Korea Neurological Biomarkers Sales Volume and Market Share by Type
    5.3 South Korea Neurological Biomarkers Sales Volume and Market Share by Application

6 Taiwan Neurological Biomarkers (Volume, Value and Sales Price)
    6.1 Taiwan Neurological Biomarkers Sales and Value ( 2014-2019)
        6.1.1 Taiwan Neurological Biomarkers Sales Volume and Growth Rate ( 2014-2019)
        6.1.2 Taiwan Neurological Biomarkers Revenue and Growth Rate ( 2014-2019)
        6.1.3 Taiwan Neurological Biomarkers Sales Price Trend ( 2014-2019)
    6.2 Taiwan Neurological Biomarkers Sales Volume and Market Share by Type
    6.3 Taiwan Neurological Biomarkers Sales Volume and Market Share by Application

7 India Neurological Biomarkers (Volume, Value and Sales Price)
    7.1 India Neurological Biomarkers Sales and Value ( 2014-2019)
        7.1.1 India Neurological Biomarkers Sales Volume and Growth Rate ( 2014-2019)
        7.1.2 India Neurological Biomarkers Revenue and Growth Rate ( 2014-2019)
        7.1.3 India Neurological Biomarkers Sales Price Trend ( 2014-2019)
    7.2 India Neurological Biomarkers Sales Volume and Market Share by Type
    7.3 India Neurological Biomarkers Sales Volume and Market Share by Application

8 Southeast Asia Neurological Biomarkers (Volume, Value and Sales Price)
    8.1 Southeast Asia Neurological Biomarkers Sales and Value ( 2014-2019)
        8.1.1 Southeast Asia Neurological Biomarkers Sales Volume and Growth Rate ( 2014-2019)
        8.1.2 Southeast Asia Neurological Biomarkers Revenue and Growth Rate ( 2014-2019)
        8.1.3 Southeast Asia Neurological Biomarkers Sales Price Trend ( 2014-2019)
    8.2 Southeast Asia Neurological Biomarkers Sales Volume and Market Share by Type
    8.3 Southeast Asia Neurological Biomarkers Sales Volume and Market Share by Application

9 Australia Neurological Biomarkers (Volume, Value and Sales Price)
    9.1 Australia Neurological Biomarkers Sales and Value ( 2014-2019)
        9.1.1 Australia Neurological Biomarkers Sales Volume and Growth Rate ( 2014-2019)
        9.1.2 Australia Neurological Biomarkers Revenue and Growth Rate ( 2014-2019)
        9.1.3 Australia Neurological Biomarkers Sales Price Trend ( 2014-2019)
    9.2 Australia Neurological Biomarkers Sales Volume and Market Share by Type
    9.3 Australia Neurological Biomarkers Sales Volume and Market Share by Application

10 Asia-Pacific Neurological Biomarkers Players/Suppliers Profiles and Sales Data
    10.1 Thermo Fisher Scientific (U.S.)
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Neurological Biomarkers Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.1.4 Main Business/Business Overview
    10.2 Qiagen (Germany)
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Neurological Biomarkers Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Qiagen (Germany) Neurological Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.2.4 Main Business/Business Overview
    10.3 Myriad RBM (U.S.)
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Neurological Biomarkers Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Myriad RBM (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.3.4 Main Business/Business Overview
    10.4 Proteome Sciences (UK)
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Neurological Biomarkers Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Proteome Sciences (UK) Neurological Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.4.4 Main Business/Business Overview
    10.5 Banyan Biomarkers (U.S.)
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Neurological Biomarkers Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Banyan Biomarkers (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.5.4 Main Business/Business Overview
    10.6 Cisbio Bioassays (U.S.)
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Neurological Biomarkers Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Cisbio Bioassays (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.6.4 Main Business/Business Overview
    10.7 Abiant (U.S.)
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Neurological Biomarkers Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Abiant (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.7.4 Main Business/Business Overview
    10.8 Acumen Pharmaceuticals (U.S.)
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Neurological Biomarkers Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.8.4 Main Business/Business Overview
    10.9 Proteosys (Germany)
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Neurological Biomarkers Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Proteosys (Germany) Neurological Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.9.4 Main Business/Business Overview
    10.10 Alseres Pharmaceuticals (U.S.)
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Neurological Biomarkers Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.10.4 Main Business/Business Overview
    10.11 Athena Diagnostics (U.S.)

11 Neurological Biomarkers Manufacturing Cost Analysis
    11.1 Neurological Biomarkers Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Neurological Biomarkers

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Neurological Biomarkers Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Neurological Biomarkers Major Manufacturers  in 2018
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Neurological Biomarkers Market Forecast ( 2019-2025)
    15.1 Asia-Pacific Neurological Biomarkers Sales Volume, Revenue and Price Forecast ( 2019-2025)
        15.1.1 Asia-Pacific Neurological Biomarkers Sales Volume and Growth Rate Forecast ( 2019-2025)
        15.1.2 Asia-Pacific Neurological Biomarkers Revenue and Growth Rate Forecast ( 2019-2025)
        15.1.3 Asia-Pacific Neurological Biomarkers Price and Trend Forecast ( 2019-2025)
    15.2 Asia-Pacific Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast by Region ( 2019-2025)
        15.2.1 Asia-Pacific Neurological Biomarkers Sales Volume and Growth Rate Forecast by Region ( 2019-2025)
        15.2.2 Asia-Pacific Neurological Biomarkers Revenue and Growth Rate Forecast by Region ( 2019-2025)
        15.2.3 China Neurological Biomarkers Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.4 Japan Neurological Biomarkers Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.5 South Korea Neurological Biomarkers Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.6 Taiwan Neurological Biomarkers Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.7 India Neurological Biomarkers Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.8 Southeast Asia Neurological Biomarkers Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.9 Australia Neurological Biomarkers Sales, Revenue and Growth Rate Forecast ( 2019-2025)
    15.3 Asia-Pacific Neurological Biomarkers Sales, Revenue and Price Forecast by Type ( 2019-2025)
        15.3.1 Asia-Pacific Neurological Biomarkers Sales Forecast by Type ( 2019-2025)
        15.3.2 Asia-Pacific Neurological Biomarkers Revenue Forecast by Type ( 2019-2025)
        15.3.3 Asia-Pacific Neurological Biomarkers Price Forecast by Type ( 2019-2025)
    15.4 Asia-Pacific Neurological Biomarkers Sales Forecast by Application ( 2019-2025)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer